Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | VINCERX PHARMA, INC VINC | TANG CAPITAL PARTNERS LP | 51,532 4.900% | 26,532 (+106.13%) | Filing History |
| 2022-02-14 11:22 am Sale | 2021-12-31 | 13G | VINCERX PHARMA, INC VINC | PUTNAM INVESTMENTS LLC | 0 0.000% | -25,000 (Position Closed) | Filing History |
| 2022-02-14 09:32 am Sale | 2021-12-31 | 13G | VINCERX PHARMA, INC VINC | RTW Investments, LP | 37,062 3.500% | -438 (-1.17%) | Filing History |
| 2022-02-11 4:13 pm Purchase | 2021-12-31 | 13G | VINCERX PHARMA, INC VINC | Affinity Asset Advisors LLC | 56,768 5.390% | 2,957 (+5.50%) | Filing History |
| 2022-02-10 12:41 pm Purchase | 2022-01-31 | 13G | VINCERX PHARMA, INC VINC | Rubric Capital Management LP | 105,350 10.006% | 105,350 (New Position) | Filing History |
| 2021-11-22 2:50 pm Purchase | 2021-11-10 | 13G | VINCERX PHARMA, INC VINC | Affinity Asset Advisors LLC | 53,811 5.120% | 53,811 (New Position) | Filing History |
| 2021-09-28 11:29 am Purchase | 2021-09-20 | 13G | VINCERX PHARMA, INC VINC | James E. Flynn | 68,966 6.560% | 68,966 (New Position) | Filing History |
| 2021-08-04 2:23 pm Unchanged | 2021-03-04 | 13G | VINCERX PHARMA, INC VINC | SAGE RHINO CAPITAL LLC | 0 0.000% | 0 (Unchanged) | Filing History |